Surgery plus immunotherapy: new hope for advanced lung cancer?
NCT ID NCT07177105
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study looks at whether removing the main lung tumor before giving immunotherapy (sintilimab) and chemotherapy can help people with advanced non-small cell lung cancer live longer without the disease getting worse. About 118 adults aged 18-75 with a specific type of lung cancer will be randomly assigned to either have surgery followed by drug treatment or just drug treatment alone. The goal is to see if adding surgery improves outcomes like survival and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.